A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis
Sigurgeirsson, Bárður, MD, PhD, van Rossem, Koen, MD, PhD, Malahias, Steven, BS, Raterink, Kerry, MS
Published in Journal of the American Academy of Dermatology (01.09.2013)
Published in Journal of the American Academy of Dermatology (01.09.2013)
Get full text
Journal Article